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background: The frequency and clinical impact of attenuated plaque (AP) has not been examined in a large-scale clinical study.
Methods: ADAPT-DES was a prospective multicenter study of 8,582 pts undergoing percutaneous coronary intervention (PCI) using drug-eluting 
stents. In a pre-specified intravascular ultrasound (IVUS) substudy, 2,072 pts with 2,446 culprit lesions had post-PCI IVUS and were classified 
according to the identification of AP behind the stent. 894 of those lesions also had pre-PCI virtual histology (VH) IVUS.
results: AP was observed in 63.0% of lesions using pre-PCI IVUS and in 62.6% of lesions using post-PCI IVUS. Among lesions with pre-PCI AP, 78.5% 
also had post-PCI AP. Pts with pre-PCI AP were older than pts without AP. Pre-PCI IVUS showed larger reference lumen area, larger plaque burden with 
positive remodeling, and more plaque ruptures and VH thin-cap fibroatheromas (TCFA) in lesions with AP (Table). Post-PCI, in-stent lumen areas in 
lesions with AP at baseline were larger than in lesions without AP. Although peri-procedural myocardial infarction (MI) occurred more frequently in 
pts with vs without AP, there was no significant difference in the 2-year rates of major adverse cardiac events (MACE: cardiac death, MI, or stent 
thrombosis) or clinically driven target vessel revascularization (TVR).
conclusion: Except for peri-procedural MI, AP is not associated with worse long-term clinical outcomes, possibly in part due to greater stent 
expansion in AP-containing lesions.
Table
AP post PCI No AP post PCI p-value
Pre-PCI IVUS N=610 lesions N=284 lesions
Lesion length, mm2 30.8±17.0 22.7±12.9 <0.0001
Proximal reference lumen area, mm2 10.7±4.3 9.9±3.9 0.03
Plaque burden at MLA site, % 76.7 ± 10.9 73.6 ± 11.5 0.0001
Remodeling Index 1.03 ± 0.41 0.98 ± 0.31 0.06
Plaque rupture 35.6% (217) 28.9% (82) 0.05
Calcified Nodule 7.9% (48) 1.1% (3) <0.0001
VH-TCFA 56.6% (345) 41.5% (118) <0.0001
Post-PCI IVUS N=1531 lesions N=915 lesions
MLA, mm2 6.3 ± 2.4 6.0 ± 2.3 0.002
Mean lumen CSA, mm3/mm 7.9 ± 2.6 7.4 ± 2.7 <0.001
2-year follow-up N=1381 patients N=691 patients
MACE 4.8% (65) 4.0% (27) 0.41
Cardiac death 1.4% (18) 1.6% (11) 0.58
MI, total 3.6% (49) 2.4% (16) 0.13
- Peri-procedural MI 1.7% (23) 0.4% (3) 0.02
- Late MI 2.0% (26) 2.0% (13) 0.98
Stent thrombosis (definite/probable) 0.6% (8) 0.6% (4) 0.99
Clinically driven TVR 7.8% (107) 8.7% (60) 0.46
